(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Alinidine (ST567) is a negative chronotrope that was developed in the 1970s and 1980s. It causes bradycardia by inhibiting the pacemaker current by altering the maximal channel conductance and alter the voltage threshold.[1] The development of alinidine was halted because it was not sufficiently specific for its target. It also has a blocking effect on calcium channels and potassium channels. It also causes elongation of re-polarisation after an action potential.[2]
Alinidine did not improve outcomes among patients with acute myocardial infarction in a randomized controlled trial.[3]
References
- ↑ Snyders DJ, Van Bogaert P-P: Alinidine modifies the pacemaker current in sheep Purkinje fibers. Pflügers Arch 1987, 410:83-91
- ↑ Current Opinion in Pharmacology 2007, 7:208–213
- ↑ "Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.". J Am Coll Cardiol 22 (2): 407–16. 1993. doi:10.1016/0735-1097(93)90044-2. PMID 8335810.
 | Original source: https://en.wikipedia.org/wiki/Alinidine. Read more |
N
Y (what is this?) (verify)
